New Enterprise Associates 16, L.P., 10% Owner at Regulus Therapeutics Inc. (RGLS), bought 8,797,204 shares at $0.62 ($5.5M) on 2020-12-04, disclosed to the SEC on 2020-12-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 4,398,602 | $2.7M | 50.0% |
| 2 | $0.62 | 4,398,602 | $2.7M | 50.0% |
| Total | $0.62 avg | 8,797,204 | $5.5M | 100% |
| Filing → |
| MTCR | SELL | 2021-12-27 | $649K | — | Filing → |
| AKUS | BUY | 2020-07-01 | $10.0M | — | Filing → |
| TRVI | SELL | 2020-04-13 | $2K | — | Filing → |